SOBEN Pharma Robeerst

Esneux ·KBO/BCE: BE 0416.405.162

Loading dossier…

Metric	This company	Sector median	Position in the sector
Solvency	7.9%	13.8%	better than 39% of 242 sector peers
Net result	€-95k	€19k	better than 16% of 242 sector peers
Equity	€22k	€94k	better than 30% of 242 sector peers
Gross operating margin	€-44k	€319k	better than 5% of 214 sector peers
Staff costs	€28k	€279k	higher than 7% of 214 sector peers

Line item	Code	2025
Balance sheet, Assets
TOTAL ASSETS	20/58	€283k
Fixed assets	21/28	€251k
Tangible fixed assets	22/27	€159k
Financial fixed assets	28	€93k
Current assets	29/58	€32k
Stocks & contracts in progress	3	€0
Amounts receivable within one year	40/41	€27k
Cash & bank	54/58	€4k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES	10/49	€283k
Equity	10/15	€22k
Contributions / capital	10/11	€19k
Reserves	13	€3k
Accumulated profits (losses)	14	€0
Provisions & deferred taxes	16	€0
Amounts payable	17/49	€261k
Amounts payable after one year	17	€226k
Amounts payable within one year	42/48	€35k
Trade debts payable within one year	44	€1k
Income statement
Gross operating margin	9900	€-44k
Operating result	9901	€-99k
Financial income	75	€8k
Financial charges	65	€29k
Result before taxes	9903	€-120k
Income taxes	67/77	€-3
Net result for the period	9904	€-95k
Result to be appropriated	9905	€-20k

Summary